Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 15;70(6):2368-78.
doi: 10.1158/0008-5472.CAN-09-3249. Epub 2010 Mar 9.

Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin

Affiliations

Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin

Subapriya Rajamanickam et al. Cancer Res. .

Abstract

Chemoprevention is a practical and translational approach to reduce the risk of various cancers including colorectal cancer (CRC), which is a major cause of cancer-related deaths in the United States. Accordingly, here we assessed chemopreventive efficacy and associated mechanisms of long-term silibinin feeding on spontaneous intestinal tumorigenesis in the APC(min/+) mice model. Six-week-old APC(min/+) mice were p.o. fed with vehicle control (0.5% carboxymethyl cellulose and 0.025% Tween 20 in distilled water) or 750 mg silibinin/kg body weight in vehicle for 5 d/wk for 13 weeks and then sacrificed. Silibinin feeding strongly prevented intestinal tumorigenesis in terms of polyp formation in proximal, middle, and distal portions of small intestine by 27% (P < 0.001), 34% (P < 0.001), and 49% (P < 0.001), respectively. In colon, we observed 55% (P < 0.01) reduction in number of polyps by silibinin treatment. In size distribution analysis, silibinin showed significant decrease in large-size polyps (>3 mm) by 66% (P < 0.01) and 88% (P < 0.001) in middle and distal portions of small intestine, respectively. More importantly, silibinin caused a complete suppression in >3 mm sized polyps and 92% reduction in >2 to 3 mm sized polyps in colon. Molecular analyses of polyps suggested that silibinin exerts its chemopreventive efficacy by inhibiting cell proliferation, inflammation, and angiogenesis; inducing apoptosis; decreasing beta-catenin levels and transcriptional activity; and modulating the expression profile of cytokines. These results show for the first time the efficacy and associated mechanisms of long-term p.o. silibinin feeding against spontaneous intestinal tumorigenesis in the APC(min/+) mice model, suggesting its chemopreventive potential against intestinal cancers including CRC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Silibinin-feeding prevents spontaneous intestinal polyposis in APCmin+ mice. At the end of the silibinin efficacy study, results are shown for A, number of polyps/mouse in small intestine and colon, and polyp size distribution in colon; B, size distribution of polyps in proximal, middle and distal portions of small intestine; C, representative pictures of distal small intestinal polyps; and D, H&E stained sections from polyps and normally appearing crypt-villus axis from control and silibinin-treated APCmin/+ mice (100x). Bars shown in each case are mean ± SEM from 18 animals in each group. $, P<0.05; #, P<0.01; *, P<0.001 versus control; Sb, silibinin.
Figure 2
Figure 2
Silibinin-feeding reduces proliferation but induces apoptosis selectively in small intestinal polyps of APCmin/+ mice. Small intestinal segments were processed for PCNA, TUNEL and CC3 staining. Tissue sections from APCmin/+ control and silibinin-treated groups show brown-colored (A) PCNA- and (B) TUNEL-positive cells in polyps (400x). Quantitative data for (A) proliferative and (B and C) apoptotic indices were determined as number of PCNA, TUNEL-or CC3-positive cells × 100/total number of cells, respectively, and represent mean ± SEM of six animals. *, P<0.001 versus control. Polyps from distal portion of small intestine from each group were also analyzed by immunoblotting for PCNA and cleaved–PARP levels. Values of band intensity adjusted with β-actin. Sb, silibinin; CC3, cleaved caspase 3.
Figure 3
Figure 3
Silibinin-feeding inhibits HIF-1α and VEGF expression selectively in small intestinal polyps of APCmin/+ mice. Small intestinal segments were processed for HIF-1α and VEGF staining. Tissue sections from APCmin/+ control and silibinin-treated groups show brown-colored (A) HIF-1α- and (C) VEGF-positive cells in polyps (400x). Quantitative data for (B) HIF-1α and (D) VEGF are shown based on their intensity of cytoplasmic brown staining, and represent mean ± SEM of six animals. *, P<0.001 versus control; Sb, silibinin.
Figure 4
Figure 4
Silibinin feeding inhibits eNOS expression and nestin-positive microvessels selectively in small intestinal polyps of APCmin/+ mice. Small intestinal segments were processed for eNOS and nestin staining. Tissue sections from APCmin/+ control and silibinin-treated groups show brown-colored (A) eNOS- and (C) nestin-positive cells in polyps (400x). Quantification of eNOS (B) was done based on its intensity of cytoplasmic brown staining, and microvessel numbers were quantified by measuring nestin-positive cells (D) in five randomly selected fields at 400x magnification, and represent mean ± SEM of six animals. *, P<0.001 versus control. Polyps from distal portion of small intestine from each group were also analyzed by immunoblotting for eNOS and nestin levels. Values of band intensity adjusted with β-actin. Sb, silibinin.
Figure 5
Figure 5
Silibinin feeding decreases β-catenin, cyclin D1 and COX-2 expression and PGE2 levels selectively in small intestinal polyps of APCmin/+ mice and inhibits β-catenin mediated transcriptional activity in vitro. Small intestinal segments or polyps were processed for IHC analyses or estimation for (A) nuclear β-catenin, (B) cyclin D1 and (D) COX-2 and PGE2 levels as detailed in Methods. Data represent mean ± SEM of six animals. *, P<0.001 versus control. Polyps from distal portion of small intestine from each group were also analyzed by immunoblotting for β-catenin and cyclin D1 levels. Values of band intensity adjusted with β-actin. C, TOP/FOPFlash reporter activity was measured using dual luciferase assay kit from Promega as described in detail in Methods. Data shown represents mean ± SEM of three independent observations. Sb, silibinin.
Figure 6
Figure 6
Silibinin feeding modulates cytokines profile in intestinal polyps of APCmin/+ mice. Lysates from small intestinal polyps were analyzed for various cytokines by cytokine antibody array kit. A, Representative cytokines array blots from control and silibinin-treated APCmin/+ mice polyps. B, Densitometric analysis data of cytokines levels from three samples in each group are shown as fold changes by silibinin treatment to that of control.

Similar articles

Cited by

References

    1. Half E, Arber N. Colon cancer: preventive agents and the present status of chemoprevention. Expert Opin Pharmacother. 2009;10:211–9. - PubMed
    1. Rustgi AK. The genetics of hereditary colon cancer. Genes Dev. 2007;21:2525–38. - PubMed
    1. Hegde MR, Roa BB. Detecting mutations in the APC gene in familial adenomatous polyposis (FAP) Curr Protoc Hum Genet. 2006;Chapter 10(Unit 10):8. - PubMed
    1. Church JM, McGannon E, Hull-Boiner S, et al. Gastroduodenal polyps in patients with familial adenomatous polyposis. Dis Colon Rectum. 1992;35:1170–3. - PubMed
    1. Nugent KP, Spigelman AD, Phillips RK. Life expectancy after colectomy and ileorectal anastomosis for familial adenomatous polyposis. Dis Colon Rectum. 1993;36:1059–62. - PubMed

Publication types

MeSH terms